Latest News

Appreciating the Patient Journey in Specialty Pharmacy
A patient-centric approach is vital to effective specialty pharmacy services.
Study shows that routinely screening inmates for hepatitis C virus at entry may identify a significant number of cases that would have been missed through targeted testing.
Tim Boonstra, RPh, Pharmacy Manager at Fairview Center for Bleeding and Clotting Disorders, talks about new therapies for hemophilia and exciting advancements on the horizon.
Top news of the day across the health care landscape
Experts argue whether a decline in cognitive function should lead to a change in disease-modifying therapy for multiple sclerosis.
Study examines whether markers of biological aging due to cancer treatment are related to cognitive function in survivors of breast cancer.
Top news of the day across the health care landscape.
The specialty drug market saw a 16% growth rate in 2018.

Features

Health-System Specialty Pharmacies Becoming an Industry Cornerstone
A new trend is emerging as health system–based specialty pharmacies become a staple in the industry.
Payers and biopharmaceutical companies are increasingly interested in outcomes-based agreements in which payments for a treatment are based on how well it helps patients meet specific health outcomes.
Although there is a persistent need for lower prescription drug costs, this simple concept is complicated by multiple factors.
It's been nearly a year since the new 340B payment rule implemented by the Centers for Medicare and Medicaid Services went into effect.

Featured Company Profile

 
MHA Specialty Pharmacy Solutions: Patient Engagement Strategies for Your Pharmacy

Videos

Tim Boonstra, RPh, Pharmacy Manager at Fairview Center for Bleeding and Clotting Disorders, talks about new therapies for hemophilia and exciting advancements on the horizon.

Nick Calla, RPh, vice president of Industry Relations at Cardinal Health Specialty Solutions, discusses specialty areas experiencing innovative developments in therapies.

Thom Cohn, Chief Strategy Officer, Asembia, discusses special considerations for the launch of a personalized drug.

Current Issue

November/December
Volume: 9
Number: 7

Most Popular

Previous TabNext Tab
Strategic Alliance Partners
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$